BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 17573400)

  • 1. Lack of renoprotective effect of i.v. N-acetylcysteine in patients with chronic renal failure.
    Morgan PG; Georghiou M; Flynn F; Jaggar S
    Br J Anaesth; 2007 Jul; 99(1):143; author reply 143-4. PubMed ID: 17573400
    [No Abstract]   [Full Text] [Related]  

  • 2. Lack of renoprotective effect of i.v. N-acetylcysteine in patients with chronic renal failure undergoing cardiac surgery.
    Ristikankare A; Kuitunen T; Kuitunen A; Uotila L; Vento A; Suojaranta-Ylinen R; Salmenperä M; Pöyhiä R
    Br J Anaesth; 2006 Nov; 97(5):611-6. PubMed ID: 16914459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal protection by N-acetylcysteine.
    Shehabi Y
    Br J Anaesth; 2007 Feb; 98(2):270; author reply 270-1. PubMed ID: 17251216
    [No Abstract]   [Full Text] [Related]  

  • 4. Protection from contrast-induced nephropathy: is the answer in?
    Dean LS
    Catheter Cardiovasc Interv; 2003 Mar; 58(3):342-3. PubMed ID: 12594699
    [No Abstract]   [Full Text] [Related]  

  • 5. Oral acetylcysteine does not protect renal function from moderate to high doses of intravenous radiographic contrast.
    Boccalandro F; Amhad M; Smalling RW; Sdringola S
    Catheter Cardiovasc Interv; 2003 Mar; 58(3):336-41. PubMed ID: 12594698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-acetylcysteine for the prevention of acute kidney injury after cardiac surgery.
    Sisillo E; Marenzi G
    J Clin Pharmacol; 2011 Nov; 51(11):1603-10. PubMed ID: 21233303
    [No Abstract]   [Full Text] [Related]  

  • 7. A drug to prevent renal failure?
    Kellum JA
    Lancet; 2003 Aug; 362(9384):589-90. PubMed ID: 12944054
    [No Abstract]   [Full Text] [Related]  

  • 8. Prevention of acute renal failure with N-acetylcysteine--enough is enough?
    Koller H; Rosenkranz AR
    Kidney Int; 2004 Sep; 66(3):1292-3; author reply 1292-3. PubMed ID: 15327439
    [No Abstract]   [Full Text] [Related]  

  • 9. High dose of N-acetylcystein prevents acute kidney injury in chronic kidney disease patients undergoing myocardial revascularization.
    Santana-Santos E; Gowdak LH; Gaiotto FA; Puig LB; Hajjar LA; Zeferino SP; Drager LF; Shimizu MH; Bortolotto LA; De Lima JJ
    Ann Thorac Surg; 2014 May; 97(5):1617-23. PubMed ID: 24657033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does N-acetylcysteine prevent contrast-induced nephropathy during endovascular AAA repair? A randomized controlled pilot study.
    Moore NN; Lapsley M; Norden AG; Firth JD; Gaunt ME; Varty K; Boyle JR
    J Endovasc Ther; 2006 Oct; 13(5):660-6. PubMed ID: 17042662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Usefulness of N-acetylcysteine or ascorbic acid versus placebo to prevent contrast-induced acute kidney injury in patients undergoing elective cardiac catheterization: a single-center, prospective, randomized, double-blind, placebo-controlled trial.
    Brueck M; Cengiz H; Hoeltgen R; Wieczorek M; Boedeker RH; Scheibelhut C; Boening A
    J Invasive Cardiol; 2013 Jun; 25(6):276-83. PubMed ID: 23735352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-acetylcysteine versus Dopamine to Prevent Acute Kidney Injury after Cardiac Surgery in Patients with Preexisting Moderate Renal Insufficiency.
    Savluk OF; Guzelmeric F; Yavuz Y; Cevirme D; Gurcu E; Ogus H; Orki T; Kocak T
    Braz J Cardiovasc Surg; 2017; 32(1):8-14. PubMed ID: 28423123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-Acetyl Cysteine Therapy Does Not Prevent Renal Failure in High-Risk Patients Undergoing Open-Heart Surgery.
    Rababa'h AM; Deo SV; Altarabsheh SE; De Caro J; Tarboush NA; Alzoubi KH; Ababneh M; McConnell BK; Markowitz AH; Park SJ
    Heart Surg Forum; 2016 Feb; 19(1):E16-22. PubMed ID: 26913679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does the prophylactic administration of N-acetylcysteine prevent acute kidney injury following cardiac surgery?
    Ashworth A; Webb ST
    Interact Cardiovasc Thorac Surg; 2010 Sep; 11(3):303-8. PubMed ID: 20570977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-acetylcysteine and fenoldopam protect the renal function of patients with chronic renal insufficiency undergoing cardiac surgery.
    Barr LF; Kolodner K
    Crit Care Med; 2008 May; 36(5):1427-35. PubMed ID: 18434903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of N-acetylcysteine in the prevention of radiocontrast-induced nephropathy.
    Brophy DF
    Ann Pharmacother; 2002 Sep; 36(9):1466-70. PubMed ID: 12196069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preconditioning renoprotective effect of isoflurane in a rat model of virtual renal transplant.
    Su MW; Chang SS; Chen CH; Huang CC; Chang SW; Tsai YC; Lam CF
    J Surg Res; 2014 Jun; 189(1):135-42. PubMed ID: 24674838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beneficial effects of N-acetylcysteine and ebselen on renal ischemia/reperfusion injury.
    Kizilgun M; Poyrazoglu Y; Oztas Y; Yaman H; Cakir E; Cayci T; Akgul OE; Kurt YG; Yaren H; Kunak ZI; Macit E; Ozkan E; Taslipinar MY; Turker T; Ozcan A
    Ren Fail; 2011; 33(5):512-7. PubMed ID: 21545313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Commentary on "N-acetylcysteine (NAC) protects against acute kidney injury following prolonged pneumoperitoneum".
    Shebrain S
    J Surg Res; 2011 Dec; 171(2):e179-80. PubMed ID: 22001183
    [No Abstract]   [Full Text] [Related]  

  • 20. Carfilzomib-related acute kidney injury may be prevented by N-acetyl-L-cysteine.
    Wanchoo R; Khan S; Kolitz JE; Jhaveri KD
    J Oncol Pharm Pract; 2015 Aug; 21(4):313-6. PubMed ID: 24748581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.